Compare Meta Platforms Inc (META) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Meta Platforms Inc vs Tempus AI — how do they compare? Meta Platforms Inc trades at $718.67 (market cap $1.84T), while Tempus AI trades at $71.05 (market cap $12.58B). The key difference: Meta Platforms Inc is far larger — about 146.3× Tempus AI's market cap, and Meta Platforms Inc pays a 0.29% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Meta Platforms Inc for 127 Days and Tempus AI for 23 Days on average.
| META | TEM | |
|---|---|---|
Market Cap | $1.84T | $12.58B |
Volume | 15,887,049 | 7,444,569 |
Sector | Media | Broad Market / Factor |
52-Week High | $777.59 | $99.28 |
52-Week Low | $525.72 | $41.55 |
Typical Hold Time | 127 Days | 23 Days |
Enterprise Value | $1.86T | $13.21B |
Dividend Yield | 0.29% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
META trades at $718.67, down 0.37% on the day, with a bullish technical signal supported by moving averages. The company reported strong revenue growth to $201B in 2025 and maintains robust profitability with 29.84% net margins. Recent AI developments, including the Muse Spark launch, and a $21B deal with CoreWeave highlight strategic positioning. Analyst consensus is strongly bullish with an 80% buy rating and $781 price target, though legal challenges and high capital expenditures present headwinds.
META's outlook remains positive driven by AI innovation and solid fundamentals, but investors face risks from regulatory lawsuits and volatile tech sentiment. The stock offers upside to consensus targets if execution continues, yet high valuation multiples and market rotation pressures warrant caution. Balancing growth prospects with legal and competitive risks is key for medium-term performance.
Tempus AI (TEM) trades at $70.93, up 0.91% today, with a bullish technical signal and strong analyst support. The stock shows robust revenue growth, with 2026 revenue reaching $1.4B, but remains unprofitable with a net margin of -17.77%. Recent FDA clearance for its ECG-MR AI product and positive ESMO Congress abstracts highlight innovation momentum, though negative cash flow from operations and insider selling pose concerns.
Outlook is cautiously optimistic given 64% buy ratings and a $72.60 consensus target, but profitability challenges and high valuation multiples (P/S 8.61, P/B 28.27) demand scrutiny. Key risks include sustained losses, competitive pressures, and reliance on financing activities for liquidity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
